KEYNOTE-059/061/062 Highlights on MSI-H Gastric/GEJ Cancers: Is Pembro Associated With Improvements in Antitumor Activity?

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

City of Hope

www.cityofhope.org

Breast
Lung
Gastrointestinal
Genitourinary
Leukemia
Lymphoma
Myeloma
Hematologic Malignancies
Head and Neck
General Oncology
Palliative Care
Events

Playback speed

10 seconds

KEYNOTE-059/061/062 Highlights on MSI-H Gastric/GEJ Cancers: Is Pembro Associated With Improvements in Antitumor Activity?

By City of Hope FEATURING Joseph Chao

25 views

April 19, 2021

Comments 0

New Approval for Frontline Consolidation in Patients with CD19-posit…

Feat. J. Mccloskey

Expert Case Review: A Treatment Option for Adult Patients With Stage…

Feat. A. Whiteley

Gastrointestinal

Right Sizing Treatment for Locally Advanced Rectal Adenocarcinoma

City of Hope

A. Barzi

274 views

Role of TKIs After 1L IO in Advanced HCC

City of Hope

D. Li

156 views

2023 Gastro-Esophageal Update

Total Health

M. Karimi

384 views

Strategizing for Best Outcomes in Metastatic Gastric Cancer

City of Hope

A. Barzi

158 views

Evolving Paradigms in the Management of Rectal Cancer: Surveying TNT…

City of Hope

A. Barzi

88 views

KEYNOTE-059/061/062 Highlights on MSI-H Gastric/GEJ Cancers: Is Pemb…

City of Hope

J. Chao

25 views

Germline Genetics & Targeted Therapy Approaches for CRC: What Is the…

Collaborative Group of the Americas for Inherited Gastrointestinal Cancers

S. Gruber

119 views